Sonendo, Inc. (SONX)

USD 1.15

(-14.81%)

Net Debt Summary of Sonendo, Inc.

  • Sonendo, Inc.'s latest annual net debt in 2023 was 26.34 Million USD , up 23.73% from previous year.
  • Sonendo, Inc.'s latest quarterly net debt in 2024 Q2 was 6.35 Million USD , up 2.67% from previous quarter.
  • Sonendo, Inc. reported annual net debt of 21.29 Million USD in 2022, up 138.4% from previous year.
  • Sonendo, Inc. reported annual net debt of -55.44 Million USD in 2021, down -177.94% from previous year.
  • Sonendo, Inc. reported quarterly net debt of 6.19 Million USD for 2024 Q1, down -76.5% from previous quarter.
  • Sonendo, Inc. reported quarterly net debt of 26.34 Million USD for 2023 FY, up 23.73% from previous quarter.

Annual Net Debt Chart of Sonendo, Inc. (2023 - 2019)

Historical Annual Net Debt of Sonendo, Inc. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 26.34 Million USD 23.73%
2022 21.29 Million USD 138.4%
2021 -55.44 Million USD -177.94%
2020 -19.94 Million USD 68.48%
2019 -63.28 Million USD 0.0%

Peer Net Debt Comparison of Sonendo, Inc.

Name Net Debt Net Debt Difference
Acutus Medical, Inc. 12.27 Million USD -114.529%
Biotricity, Inc. 23.09 Million USD -14.071%
Cell MedX Corp. 244.05 Thousand USD -10693.646%
Dynatronics Corporation 6.2 Million USD -324.595%
Nemaura Medical Inc. 9.92 Million USD -165.41%
PetVivo Holdings, Inc. 1.27 Million USD -1961.775%
RetinalGenix Technologies Inc. 506.53 Thousand USD -5100.441%
Telesis Bio, Inc. 32.63 Million USD 19.283%
Talis Biomedical Corporation -57.06 Million USD 146.162%
Viveve Medical, Inc. -13.81 Million USD 290.704%